Answer
Emtricitabine/tenofovir disoproxil Mylan is indicated for HIV-1-infected adolescents with NRTI resistance or toxicities precluding the use of first-line agents.
Sources for this answer
- Emtricitabine/Tenofovir Disoproxil Mylan 200 mg/245 mg Film-coated TabletsViatris (formerly Mylan or Upjohn) · emc · SmPC §4.1 Therapeutic Indications · Version 9Document updated
Sources checked